Revert the SIRT: normalizing SIRT1 activity in myelodysplastic stem cells.
Affiliation
Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4JG, UKIssue Date
2018-09-06
Metadata
Show full item recordAbstract
Myelodysplastic syndromes are hematologic malignancies with few treatment options and a propensity to transform to acute myeloid leukemia. In this issue of Cell Stem Cell, Sun et al. (2018) report that low SIRT1 levels in myelodysplastic stem cells contribute to aberrant self-renewal through enabling hyperacetylation and reduced activity of TET2.Citation
Revert the SIRT: normalizing SIRT1 activity in myelodysplastic stem cells. 2018, 23(3): 315-317 Cell Stem CellJournal
Cell Stem CellDOI
10.1016/j.stem.2018.08.003PubMed ID
30193128Type
ArticleLanguage
enISSN
1875-9777ae974a485f413a2113503eed53cd6c53
10.1016/j.stem.2018.08.003
Scopus Count
Collections
Related articles
- SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.
- Authors: Sun J, He X, Zhu Y, Ding Z, Dong H, Feng Y, Du J, Wang H, Wu X, Zhang L, Yu X, Lin A, McDonald T, Zhao D, Wu H, Hua WK, Zhang B, Feng L, Tohyama K, Bhatia R, Oberdoerffer P, Chung YJ, Aplan PD, Boultwood J, Pellagatti A, Khaled S, Kortylewski M, Pichiorri F, Kuo YH, Carlesso N, Marcucci G, Jin H, Li L
- Issue date: 2018 Sep 6
- Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
- Authors: Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Martín MT, Guillamot M, Banh RS, Xu M, Figueroa ME, Dickins RA, Abdel-Wahab O, Park CY, Tsirigos A, Neel BG, Aifantis I
- Issue date: 2017 Sep 7
- Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.
- Authors: Lin TL, Nagata Y, Kao HW, Sanada M, Okuno Y, Huang CF, Liang DC, Kuo MC, Lai CL, Lee EH, Shih YS, Tanaka H, Shiraishi Y, Chiba K, Lin TH, Wu JH, Miyano S, Ogawa S, Shih LY
- Issue date: 2014 Jan
- Role of SIRT1 in hematologic malignancies.
- Authors: Huang FT, Sun J, Zhang L, He X, Zhu YH, Dong HJ, Wang HY, Zhu L, Zou JY, Huang JW, Li L
- Issue date: 2019 May
- [TET2 as a gatekeeper for hematologic malignancies].
- Authors: Muto H, Sakata-Yanagimoto M, Chiba S
- Issue date: 2015 Jun